Current Edition Of Indian Pharmacopoeia Work -

The IP 2022 is available for purchase in print and as a (e-IP) through the IPC’s official website: www.ipc.gov.in. It is not freely available in the public domain, but certain general chapters are accessible for educational purposes.

: Includes 20 new blood component monographs, expanded biological/biotech products, and harmonization of 18 general chapters and 22 excipients with major international pharmacopoeias (USP, EP, JP). Structure & Reach current edition of indian pharmacopoeia

| Parameter | IP 2018 (Previous) | IP 2022 (Current) | | :--- | :--- | :--- | | | ~2,800 | >3,000 | | Biological Products | 45 monographs | 82 monographs (including biosimilars) | | Dissolution Testing | Traditional apparatus | Added flow-through cell (USP apparatus 4) | | Chromatographic Methods | HPLC mainly | UPLC and HPTLC officially recognized | | Microbial Limits | For 5 organisms | Expanded to 12 objectionable organisms | The IP 2022 is available for purchase in

: Includes 121 new monographs , bringing the total number of monographs in the compendium to 3,340 . Structure & Reach | Parameter | IP 2018

: Harmonizes 18 general chapters and 22 excipient monographs with international standards from the Pharmacopoeial Discussion Group (PDG) , which includes the USP, BP, and JP.